| Nov 20 |
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)
|
| Nov 20 |
Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?
|
| Nov 20 |
ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System
|
| Nov 19 |
BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
|
| Nov 18 |
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
|
| Nov 18 |
ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders
|
| Nov 15 |
Here's Why You Should Add RMD Stock to Your Portfolio Now
|
| Nov 15 |
Nevro Stock May Gain on the CE Mark Certification for HFX iQ
|
| Nov 14 |
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
|
| Nov 14 |
MYGN Stock Might Gain From SneakPeek Availability in Retail Stores
|
